Ignite Creation Date:
2025-12-24 @ 2:52 PM
Ignite Modification Date:
2025-12-26 @ 1:39 PM
Study NCT ID:
NCT05535959
Status:
COMPLETED
Last Update Posted:
2022-12-12
First Post:
2022-09-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Relative Bioavailability of a Fixed-dose Combination Tablet of VX-121/Tezacaftor/Deutivacaftor
Sponsor:
Vertex Pharmaceuticals Incorporated
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-09-15
Start Date Type:
ACTUAL
Primary Completion Date:
2022-11-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-11-09
Completion Date Type:
ACTUAL
First Submit Date:
2022-09-07
First Submit QC Date:
None
Study First Post Date:
2022-09-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-12-08
Last Update Post Date:
2022-12-12
Last Update Post Date Type:
ACTUAL